Cilengitide: A Potent Integrin Inhibitor for Advanced Cancer Therapy

Explore the groundbreaking potential of Cilengitide in targeting critical pathways for cancer treatment.

Get a Quote & Sample

Key Advantages of Cilengitide

Targeted Action

Cilengitide precisely targets αvβ3 and αvβ5 integrins, minimizing off-target effects and enhancing therapeutic efficacy in cancer by blocking key cellular processes.

Inhibits Tumor Growth

By disrupting angiogenesis and influencing tumor invasion, Cilengitide acts as a powerful tool against tumor progression, offering new hope in oncology.

Synergistic Potential

Studies suggest Cilengitide can augment the effects of other cancer treatments, like radiation therapy, potentially leading to better patient outcomes.

Key Applications

Oncology Research

Essential for studying the role of integrins in cancer development and progression, aiding in the discovery of new treatment strategies.

Angiogenesis Inhibition Studies

A critical tool for researchers investigating anti-angiogenic therapies and their impact on tumor vascularization and growth.

Glioblastoma Treatment Development

Key in the research and development of novel treatments for glioblastoma, a highly aggressive brain tumor.

Integrin Signaling Pathways

Used to dissect the complex roles of integrin signaling in various cellular processes relevant to disease and therapeutic intervention.